FDA Inspection 1207827 — Immunocentrix Corporation
The FDA completed an inspection of Immunocentrix Corporation on June 1, 2023 in Canoga Park, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 1, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Canoga Park, CA (United States)